These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 25957541)
1. Participation of hMLH1, p63, and MDM2 proteins in the pathogenesis of syndromic and nonsyndromic keratocystic odontogenic tumors. de Brito Monteiro BV; Cavalcante RB; Maia Nogueira RL; da Costa Miguel MC; Weege Nonaka CF; da Silveira ÉJ Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Jul; 120(1):52-7. PubMed ID: 25957541 [TBL] [Abstract][Full Text] [Related]
2. Analysis of GLUT-1, GLUT-3, and angiogenic index in syndromic and non-syndromic keratocystic odontogenic tumors. Leite RB; Cavalcante RB; Nogueira RLM; Souza LB; Pereira Pinto L; Nonaka CFW Braz Oral Res; 2017 Apr; 31():e34. PubMed ID: 28489118 [TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical expression of protein 53, murine double minute 2, B-cell lymphoma 2, and proliferating cell nuclear antigen in odontogenic cysts and keratocystic odontogenic tumor. Galvão HC; Gordón-Núñez MA; de Amorim RF; Freitas Rde A; de Souza LB Indian J Dent Res; 2013; 24(3):369-74. PubMed ID: 24025887 [TBL] [Abstract][Full Text] [Related]
4. Relationship between the epithelial expression of hMLH1, MDM2, and p63 and lower lip carcinogenesis. de Oliveira DH; de Sousa Lopes ML; de Santana Sarmento DJ; Queiroz LM; da Costa Miguel MC; da Silveira EJ J Oral Pathol Med; 2014 May; 43(5):357-63. PubMed ID: 24329813 [TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical comparison of the expression of p53 and MDM2 proteins in ameloblastomas and keratocystic odontogenic tumors. Sharifi-Sistani N; Zartab H; Babakoohi S; Saghravanian N; Jamshidi S; Esmaili H; Mohtasham N; Zamanzadeh M; Abbaszadeh-Bidokhty H J Craniofac Surg; 2011 Sep; 22(5):1652-6. PubMed ID: 21959406 [TBL] [Abstract][Full Text] [Related]
6. Expression of Ki-67, p53 and p63 proteins in keratocyst odontogenic tumours: an immunohistochemical study. Gurgel CA; Ramos EA; Azevedo RA; Sarmento VA; da Silva Carvalho AM; dos Santos JN J Mol Histol; 2008 Jun; 39(3):311-6. PubMed ID: 18256893 [TBL] [Abstract][Full Text] [Related]
7. Cell proliferation and apoptosis in keratocystic odontogenic tumors. Mateus GC; Lanza GH; de Moura PH; Marigo Hde A; Horta MC Med Oral Patol Oral Cir Bucal; 2008 Nov; 13(11):E697-702. PubMed ID: 18978709 [TBL] [Abstract][Full Text] [Related]
8. Beta-catenin and survivin expression in keratocystic odontogenic tumor (KCOT). A comparative immunohistochemical study in primary, recurrent and nevoid basal cell carcinoma syndrome (NBCCS)-associated lesions. Leonardi R; Matthews JB; Loreto C; Musumeci G; Campisi G; Lo Muzio L; dos Santos JN; Pastorino L; Bufo P; Pannone G Histol Histopathol; 2013 Sep; 28(9):1175-84. PubMed ID: 23572266 [TBL] [Abstract][Full Text] [Related]
9. Immunoexpression of hMSH2 and hMLH1 in oral squamous cell carcinoma and its relationship to histological grades of malignancy. Fernandes AM; Ramos-Jorge ML; Cardoso SV; Loyola AM; Mesquita RA; Aguiar MC J Oral Pathol Med; 2008 Oct; 37(9):543-8. PubMed ID: 18331286 [TBL] [Abstract][Full Text] [Related]
13. Odontogenic epithelium: immunolabeling of Ki-67, EGFR and survivin in pericoronal follicles, dentigerous cysts and keratocystic odontogenic tumors. de Oliveira MG; Lauxen Ida S; Chaves AC; Rados PV; Sant'Ana Filho M Head Neck Pathol; 2011 Mar; 5(1):1-7. PubMed ID: 21053110 [TBL] [Abstract][Full Text] [Related]
14. Immunolocalisation of laminin-1 in keratocystic odontogenic tumors. Silva Gurgel CA; Gonçalves Ramos EA; Araújo Melo L; Brandi Schlaepfer C; de Souza RO; Campos Oliveira M; dos Santos JN Acta Histochem; 2010 Nov; 112(6):624-9. PubMed ID: 19773031 [TBL] [Abstract][Full Text] [Related]
15. Differential diagnosis of atypical epithelium of biopsied gastric mucosa using immunostaining of Ki-67, p53, hMLH1 and MDM2 expression. Ito E; Saito K; Takizawa T; Koike M J Exp Clin Cancer Res; 2002 Dec; 21(4):527-37. PubMed ID: 12636099 [TBL] [Abstract][Full Text] [Related]
16. Low hMLH1 expression prior to definitive chemoradiotherapy predicts poor prognosis in esophageal squamous cell carcinoma. Nam TK; Lee JH; Cho SH; Chung IJ; Ahn SJ; Song JY; Yoon MS; Chung WK; Nah BS Cancer Lett; 2008 Feb; 260(1-2):109-17. PubMed ID: 18053639 [TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical analysis of hMLH1 and hMSH2 proteins in serous ovarian tumours. Stasikowska-Kanicka O; Stawerski P; Wagrowska-Danilewicz M; Danilewicz M Pol J Pathol; 2009; 60(4):174-8. PubMed ID: 20072951 [TBL] [Abstract][Full Text] [Related]
18. p63 expression correlates with pathological features and biological behaviour of odontogenic tumours. Lo Muzio L; Santarelli A; Caltabiano R; Rubini C; Pieramici T; Giannone N; Carinci F; Leonardi R; Lanzafame S; Piattelli A Histopathology; 2006 Aug; 49(2):211-4. PubMed ID: 16879406 [No Abstract] [Full Text] [Related]
19. Defective mismatch repair and the development of recurrent endometrial carcinoma. Pijnenborg JM; Dam-de Veen GC; de Haan J; van Engeland M; Groothuis PG Gynecol Oncol; 2004 Aug; 94(2):550-9. PubMed ID: 15297202 [TBL] [Abstract][Full Text] [Related]
20. The occurrence of keratocystic odontogenic tumours in nevoid basal cell carcinoma syndrome. Lam EW; Lee L; Perschbacher SE; Pharoah MJ Dentomaxillofac Radiol; 2009 Oct; 38(7):475-9. PubMed ID: 19767519 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]